RITUXAN for Rheumatoid Arthritis Support Line: 1-877-474-8892.
 

Get more Rituxan information

Sign up to receive FREE Rituxan educational materials and support services.

Click here
Text Zoom
Glossary
ONONOFFOFF
 

PrintReimbursement

At Genentech, we develop medicines for serious or life-threatening medical conditions and we believe medicines should be effective, safe and accessible to the patients who need them

Genentech Access Solutions provides coverage and reimbursement support, patient assistance and informational resources for both patients and their health care providers

Genentech Access Solutions

At Genentech Access Solutions, we're here to help find a way for you to get the medicine your doctor has prescribed, even if you have no insurance or have a problem paying for Rituxan.

When you or your doctor's office call Genentech Access Solutions, you will connect with one of our experts, whose sole job is to make sure that you get the coverage or reimbursement help you need.

At Genentech Access Solutions, we work hard to make information you need about coverage and reimbursement easily available 24 hours a day:

  • via phone at 1-877-4RITUXAN (1-877-474-8892), then press 2, between the hours of 6 a.m. and 5 p.m. PST Monday through Friday or
  • 24/7 through our website at www.GenentechAccessSolutions.com

Genentech® Access to Care Foundation

The Genentech Access to Care Foundation was established to help qualified patients with unmet medical needs to receive proper medical treatment. The Genentech Access to Care Foundation may be available to help those who are not able to obtain Rituxan for financial reasons.

  • If you have no insurance, or you are effectively uninsured because your health insurance plan denies you access to Rituxan, you can apply to the Genentech Access to Care Foundation for help with your treatment.
  • We recognize the financial burdens that some patients and their families may experience in gaining access to Rituxan. We are committed to assisting all eligible patients obtain access to our medicines, regardless of their ability to pay.
  • For eligible patients who are treated in the United States, the Genentech Access to Care Foundation will provide Rituxan to those who cannot afford to pay for it because it is the right thing to do.